Search results
Opioids Lawyers Offer Investors Piece of $100 Million-Plus Win
Bloomberg Law· 5 days agoA law firm set to earn more than $100 million for its work on opioids cases is packaging its fees and selling it to investors as a security. Napoli Shkolnik PLLC is pooling ...
Nurix Therapeutics CFO Hans van Houte sells $400k in company stock By Investing.com
Investing.com· 2 days agoIn a recent stock transaction, Hans van Houte, Chief Financial Officer of Nurix Therapeutics, Inc....
Roche shares hold as analyst backs Buy rating By Investing.com
Investing.com· 5 days agoAt the EHA meeting, Roche revealed pivotal details of Columvi in a phase 3 study (STARGLO P3)...
Emergent BioSolutions sells Baltimore facility to Bora Pharmaceuticals By Investing.com
Investing.com· 2 days ago(NYSE: EBS), a biopharmaceutical company, has struck a deal to divest its Baltimore-Camden drug...
Baird lifts Mirum Pharmaceuticals shares target on study results By Investing.com
Investing.com· 5 days agoThe revision follows the announcement of positive clinical trial results for Mirum's drug candidate...
Decades of gene therapy research pay off big for Madison company
Wisconsin State Journal· 2 days agoThirty years ago, when the idea that would give rise to Mirus Bio took shape in a UW-Madison...
A Trojan horse for government price-setting
Dallas Morning News· 5 days agoA court motion filed by the Biden administration could put Americans on the hook for billions of dollars in damages incurred by a private company, and...
Novo Nordisk multibillion-dollar expansion in North Carolina appears imminent - Triangle Business...
The Business Journals· 5 days agoA multibillion-dollar expansion in Johnston County appears to be imminent for one of the world's...
Disease, weather lead to orange juice crisis
The Times and Democrat· 5 hours agoJust as the world is coming out of the tea crisis, another breakfast staple, orange juice, is in the spotlight. The primary cause of this orange juice...
TD Cowen starts Alkermes stock coverage with Buy By Investing.com
Investing.com· 5 days agoOn Monday, TD Cowen initiated coverage on shares of Alkermes (NASDAQ:ALKS), assigning a Buy rating...
